Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CASIRIVIMAB vs CASIRIVIMAB\IMDEVIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CASIRIVIMAB vs CASIRIVIMAB\IMDEVIMAB: Safety Overview

Metric CASIRIVIMAB CASIRIVIMAB\IMDEVIMAB
Total FAERS Reports 500 4,248
Deaths Reported 24 137
Death Rate 4.8% 3.2%
Hospitalizations 209 1,351
Average Patient Age 58.9 yrs 54.3 yrs
% Female Patients 52.4% 55.4%